SONIB 200MG

Description

SONIB 200MG

Description:

SONIB 200MG is a medicine that comprises Imatinib Mesylate and is a tyrosine kinase inhibitor that is normally used in treatment of some kinds of cancers. It is manufactured under British Pharmacopoeia (BP) guidelines and this guarantees high level of formulation and efficacy.

Key Features:

Imatinib Mesylate 200 mg

Pharmacopoeia: BP (British Pharmacopoeia)

Form: Film covered tablet

Blister pack

Uses / Indications:

Chronic Myeloid Leukemia (CML)

Acute Lymphoblastic Leukemia (ALL)

Gastrointestinal Stromal Tumors (GIST)

Other solid tumors and leukemia positive with Philadelphia chromosome according to prescription. Imatinib causes the BCR-ABL tyrosine kinase enzyme to remain on hold, preventing the proliferation of the cancer cells as the signals that result into cancerous cell growth and division are blocked.

Dosage:
Under the guidance of a medical practitioner (according to the state of patients and the degree of the disease).

Storage:
Store at not more than 25 o C, avoid light and moisture. Children should not be allowed to reach it.